Mali vs Senegal: Treatment coverage for schistosomiasis
Mali
39.3%
in 2024
Senegal
39.7%
in 2024
Mali rank
30th
Senegal rank
29th
Treatment coverage for schistosomiasis over time
- Mali
- Senegal
How they compare
Senegal currently reports 39.7% against 39.3% in Mali, a difference of 0.4%.
The two have swapped places 5 times across 16 shared years of data; in 2006 it was Mali ahead.
Mali ranks 30th and Senegal ranks 29th of 45 countries.
Mali has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Mali | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.0% | 1.7% | 11.3% | Mali |
| 2010s | 55.3% | 36.6% | 18.7% | Mali |
| 2020s | 40.8% | 38.3% | 2.5% | Mali |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Mali or Senegal?
- Senegal, at 39.7% against 39.3% in Mali as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Mali and Senegal?
- 0.4%, with Senegal ahead.
- How many years of comparable data are there for Mali and Senegal?
- 16 years are reported by both, from 2006 to 2024.
- How do Mali and Senegal rank globally for treatment coverage for schistosomiasis?
- Mali ranks 30th and Senegal ranks 29th of 45 countries.
- Where does this data come from?
- World Health Organization (2025) β with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.